These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17333568)

  • 21. Malignant melanoma: current trends and future prospects.
    Murray JL; Schosser RH; Bottomley RH
    J Okla State Med Assoc; 1980 Nov; 73(11):377-81. PubMed ID: 7431141
    [No Abstract]   [Full Text] [Related]  

  • 22. Melanoma of the head and neck: a review.
    Korkolis D; Liapakis IE; Gherardini G; Kokkalis G; Vassilopoulos P
    J BUON; 2007; 12(3):329-34. PubMed ID: 17918285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccine therapy for melanoma: current status and future directions.
    Terando AM; Faries MB; Morton DL
    Vaccine; 2007 Sep; 25 Suppl 2():B4-16. PubMed ID: 17646038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant melanoma.
    Tarpey AM
    Prof Nurse; 2001 Sep; 17(1):15-6. PubMed ID: 12030139
    [No Abstract]   [Full Text] [Related]  

  • 25. Melanoacanthoma of the external auditory canal: a case report and review of the literature.
    Cheng AG; Deubner H; Whipple ME
    Am J Otolaryngol; 2007; 28(6):433-5. PubMed ID: 17980780
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical trials referral resource. Current trials in melanoma.
    Saxman SB; Smiley JK; Cheson BD
    Oncology (Williston Park); 1999 Sep; 13(9):1239-42. PubMed ID: 10509321
    [No Abstract]   [Full Text] [Related]  

  • 27. [New directions in melanoma therapy].
    Tüting T
    J Dtsch Dermatol Ges; 2008 Oct; 6(10):815-6. PubMed ID: 18992024
    [No Abstract]   [Full Text] [Related]  

  • 28. Metastatic malignant melanoma of the small intestine: capsule endoscopic appearance.
    Smedegaard J; Adamsen S
    Endoscopy; 2007 Feb; 39 Suppl 1():E209. PubMed ID: 17614047
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunology and melanoma. Theoretical-experimental observations].
    Jurado A; Céspedes de Gómez M
    Alergia; 1981 Oct; 28(4):145-72. PubMed ID: 7332071
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunotherapy of advanced or metastatic melanoma.
    Cebon J; Gedye C; John T; Davis ID
    Clin Adv Hematol Oncol; 2007 Dec; 5(12):994-1006. PubMed ID: 18277962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in prognostication of cutaneous malignant melanoma.
    Penmatcha S; Rovinsky SA; Cockerell CJ; Hsu MY
    Adv Dermatol; 2004; 20():323-43. PubMed ID: 15544206
    [No Abstract]   [Full Text] [Related]  

  • 32. More than skin deep.
    Davis C
    Nurs Times; 2002 Jul 16-22; 98(29):25. PubMed ID: 12168411
    [No Abstract]   [Full Text] [Related]  

  • 33. Your patient with melanoma: staging, prognosis, and treatment.
    Rubin KM; Lawrence DP
    Oncology (Williston Park); 2009 Jul; 23(8 Suppl):13-21. PubMed ID: 19860037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short German guidelines: malignant melanoma.
    Garbe C; Schadendorf D; Stolz W; Volkenandt M; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R; Hauschild A
    J Dtsch Dermatol Ges; 2008 May; 6 Suppl 1():S9-S14. PubMed ID: 18801142
    [No Abstract]   [Full Text] [Related]  

  • 35. Melanoma genomics reveals signatures of sensitivity to bio- and targeted therapies.
    Tímár J; Mészáros L; Ladányi A; Puskás LG; Rásó E
    Cell Immunol; 2006 Dec; 244(2):154-7. PubMed ID: 17433276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immune system--a hidden treasure for biomarker discovery in cutaneous melanoma.
    Neagu M
    Adv Clin Chem; 2012; 58():89-140. PubMed ID: 22950344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CEACAM1 in malignant melanoma: a diagnostic and therapeutic target.
    Sapoznik S; Ortenberg R; Schachter J; Markel G
    Curr Top Med Chem; 2012; 12(1):3-10. PubMed ID: 22196267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterologous prime-boost immunotherapy of melanoma patients with Influenza virosomes, and recombinant Vaccinia virus encoding 5 melanoma epitopes and 3 co-stimulatory molecules. A multi-centre phase I/II open labeled clinical trial.
    Adamina M; Weber WP; Rosenthal R; Schumacher R; Zajac P; Guller U; Frey DM; Oertli D; Zuber M; Heberer M; Spagnoli GC
    Contemp Clin Trials; 2008 Mar; 29(2):165-81. PubMed ID: 17707139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melanoma immunotherapy: new dreams or solid hopes?
    Maio M; Parmiani G
    Immunol Today; 1996 Sep; 17(9):405-7. PubMed ID: 8854555
    [No Abstract]   [Full Text] [Related]  

  • 40. Recent aspects of medical care of malignant melanoma.
    Terheyden P; Tilgen W; Hauschild A
    J Dtsch Dermatol Ges; 2008 Oct; 6(10):868-78, 868-80. PubMed ID: 18992025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.